Jefferies Group LLC Trillium Therapeutics Inc. Transaction History
Jefferies Group LLC
- $10.2 Billion
- Q3 2022
A detailed history of Jefferies Group LLC transactions in Trillium Therapeutics Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 29,000 shares of TRIL stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,000Holding current value
$0% of portfolio
0.0%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
About Trillium Therapeutics Inc.
- Ticker TRIL
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 104,995,000
- Market Cap $1.94B